ROTOP Radiopharmacy is located in the former PET center of the Helmholtz-Zentrum Dresden-Rossendorf and was inaugurated in 2020. In the modernized building there are three hot cells in which high activities of Iodine-123 can be processed and Ioflupane (123I) is manufactured under cGMP conditions.
The proprietary API was developed and produced entirely in-house. This precursor is used for Ioflupane production and provided to third parties.
Ioflupane (123I) ROTOP is distributed in environmentally friendly Type-A packaging all over Europe and we hold marketing authorizations in more then 10 european countries. In compliance with high radiation protection standards, we developed fully-automated cGMP labeling and packaging software to package and deliver Ioflupane from Dresden.